Fludarabine, cytarabine, and attenuated-dose idarubicin (m-FLAI) combination therapy for elderly acute myeloid leukemia patients.
about
Frontline therapy of AML: should the older patient be treated differently?Management of Newly Diagnosed Acute Myeloid Leukemia in the Elderly: Current Strategies and Future Directions.The fludarabine, cytarabine, and granulocyte colony-stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline-based therapy for the treatment of acute myeloid leukemia for patients with pre-existing cardiac disease.Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG.
P2860
Fludarabine, cytarabine, and attenuated-dose idarubicin (m-FLAI) combination therapy for elderly acute myeloid leukemia patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Fludarabine, cytarabine, and a ...... ute myeloid leukemia patients.
@en
Fludarabine, cytarabine, and a ...... ute myeloid leukemia patients.
@nl
type
label
Fludarabine, cytarabine, and a ...... ute myeloid leukemia patients.
@en
Fludarabine, cytarabine, and a ...... ute myeloid leukemia patients.
@nl
prefLabel
Fludarabine, cytarabine, and a ...... ute myeloid leukemia patients.
@en
Fludarabine, cytarabine, and a ...... ute myeloid leukemia patients.
@nl
P2093
P2860
P356
P1476
Fludarabine, cytarabine, and a ...... cute myeloid leukemia patients
@en
P2093
Byoung Kook Kim
Chul-Soo Kim
Dae-Sik Hong
Dae-Young Kim
Eunkyung Park
Hong-Kee Lee
Je-Hwan Lee
Jong-Ho Won
P2860
P356
10.1002/AJH.23337
P577
2012-10-17T00:00:00Z